These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 7724021)
41. Cell cholesterol transport to plasma in blood from patients with renal failure or a kidney transplant. Sutherland WH; Corboy J; Walker RJ; Robertson MC; Ball MJ Nephrol Dial Transplant; 1995; 10(3):358-65. PubMed ID: 7792031 [TBL] [Abstract][Full Text] [Related]
42. Effects of low molecular weight heparin on the frequencies of intradialytic arrhythmias in hemodialysis patients. Miyauchi H; Matsumoto Y; Futenma A; Amano I; Miyauchi J; Matsuo S Ren Fail; 2006; 28(6):469-74. PubMed ID: 16928615 [TBL] [Abstract][Full Text] [Related]
43. The free fraction of paraoxonase 1 is not increased in patients with end stage renal disease undergoing hemodialysis. Gugliucci A; Schulze J; Kinugasa E; Ogata H; Kimura S Clin Chim Acta; 2009 Apr; 402(1-2):209-10. PubMed ID: 19150443 [No Abstract] [Full Text] [Related]
44. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay. Harenberg J; Haaf B; Dempfle CE; Stehle G; Heene DL Nephrol Dial Transplant; 1995; 10(2):217-22. PubMed ID: 7753456 [TBL] [Abstract][Full Text] [Related]
45. [Heparin and lipoprotein(a). Observations during hemodialysis]. Salvini P; Maddaloni E; Levi della Vida MV; Parma A; Corpetti MG; Di Lorenzo M Recenti Prog Med; 1993 Dec; 84(12):828-33. PubMed ID: 8108596 [TBL] [Abstract][Full Text] [Related]
46. Correlation of serum magnesium and serum lipid levels in hemodialysis patients. Robles NR; Escola JM; Albarran L; Espada R Nephron; 1998; 78(1):118-9. PubMed ID: 9453415 [No Abstract] [Full Text] [Related]
47. Long-term effects of low molecular weight heparin on lipid parameters in hemodialysis patients. Elisaf MS; Bairaktari H; Germanos N; Pappas M; Koulouridis E; Papagalanis N; Siamopoulos KC Int Angiol; 1996 Sep; 15(3):252-6. PubMed ID: 8971586 [TBL] [Abstract][Full Text] [Related]
49. Dyslipidemia in patients with chronic renal failure and in renal transplant patients. Shah B; Nair S; Sirsat RA; Ashavaid TF; Nair KG J Postgrad Med; 1994; 40(2):57-60. PubMed ID: 8737552 [TBL] [Abstract][Full Text] [Related]
50. Lipid and lipoprotein metabolism in chronic kidney disease. Kaysen GA J Ren Nutr; 2009 Jan; 19(1):73-7. PubMed ID: 19121776 [TBL] [Abstract][Full Text] [Related]
51. Does ingestion of regular coffee influence serum lipid profile in dialysis patients? Grzegorzewska AE; Młot-Michalska M; Wobszal P Adv Perit Dial; 2009; 25():181-6. PubMed ID: 19886342 [TBL] [Abstract][Full Text] [Related]
52. [Lipids and lipoproteins in acute renal failure]. Mydlík M; Ahlers I; Takác M; Derzsiová K; Jarcuska J Cas Lek Cesk; 1975 Mar; 114(10-11):337-41. PubMed ID: 1139582 [No Abstract] [Full Text] [Related]
53. Calciphylaxis in a haemodialysis patient: functional protein S deficiency? Perez-Mijares R; Guzman-Zamudio JL; Payan-Lopez J; Rodriguez-Fernandez A; Gomez-Fernandez P; Almaraz-Jimenez M Nephrol Dial Transplant; 1996 Sep; 11(9):1856-9. PubMed ID: 8918640 [No Abstract] [Full Text] [Related]
54. The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane. Chanard J; Lavaud S; Maheut H; Kazes I; Vitry F; Rieu P Nephrol Dial Transplant; 2008 Jun; 23(6):2003-9. PubMed ID: 18156457 [TBL] [Abstract][Full Text] [Related]
56. [Assessment of malonyldialdehyde concentration as a product of lipid peroxidation and lipid metabolism in patients on chronic dialysis]. Miler M; Zamojska S; Fijałkowski P; Lobos M; Paradowski MT Pol Merkur Lekarski; 2006 Jun; 20(120):664-7. PubMed ID: 17007263 [TBL] [Abstract][Full Text] [Related]
59. [Complications of extracorporeal hemosorption and their prevention]. Mazur LI; Nikolaĭchik VV; Astapenko VG; Ostapenko VA Vestn Khir Im I I Grek; 1983 Jun; 130(6):114-9. PubMed ID: 6612925 [TBL] [Abstract][Full Text] [Related]